Defect reperfusion imaging, a newly developed novel technology using sonazoid in the treatment of hepatocellular carcinoma

Journal of Medical Ultrasound

Volumn 16, Issue 3, 2008, Pages 169-176

  Kudo, Masatoshi ^a   Hatanaka, Kinuyo ^a   Maekawa, Kiyoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast enhanced harmonic ultrasound; Hepatic tumors; Kupffer phase imaging; Radiofrequency ablation; Treatment assist guidance

Indexed keywords

PERFLUBUTANE; PERFLUTREN; SHU 508; SONOVUE;

B SCAN; CANCER STAGING; CONTRAST ENHANCEMENT; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG HYPERSENSITIVITY; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; REAL TIME ECHOGRAPHY; REPERFUSION; REVIEW; SCREENING TEST; TUMOR RECURRENCE;

EID: 56349128362     PISSN: 09296441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6441(08)60045-4     Document Type: Review

References (13)

1. Kudo M. Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors. Tokyo: Springer Verlag, 2003:1-253.
2. Wen YL, Kudo M, Zheng RQ, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004;182:1019-26.
3. Ding H, Kudo M, Onda H, et al. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001;220:349-56.
4. Inoue T, Kudo M, Watai R, et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2005;40:1139-47.
5. Ding H, Kudo M, Onda H, et al. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2001;176:661-6.
6. Minami Y, Kudo M, Kawasaki T, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;180:703-8.
7. Ding H, Kudo M, Onda H, et al. Evaluation of post-treatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221:721-30.
8. Minami Y, Kudo M, Kawasaki T, et al. Treatment of hepatocellular carcinoma with percutaneous radio-frequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004;183:153-6.
9. Minami Y, Kudo M, Chung H, et al. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007;188:489-94.
10. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;181:57-63.
11. Kudo M, Hatanaka K, Chung H, et al. A proposal of novel treatment-assist technique for hepatocellular carcinoma in Sonazoid-enhanced ultrasonography: value of defect reperfusion imaging. Acta Hepato Jpn 2007;48:299-301. [In Japanese]
12. Minami Y, Kudo M, Chung H, et al. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors: feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007;72(Suppl 1):111-6.
13. Kudo M. Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol 2004;39:205-14.